Covid Vaccine for Children: Government approves first Covid-19 vaccine for children above 12 years | India News


NEW DELHI: Zydus Cadila’s locally developed anti-Covid jab ZyCoV-D secured a regulatory approval on Friday for emergency use, becoming the world’s first DNA based vaccine for Covid-19 to be administered in children and adults of age 12 years and above.
The company has indicated an initial visibility of supplying around 5 crore doses by December, a senior official said.
While the government is yet to sign a final agreement with Cadila, supplies to the national programme are likely to begin by September end, he added.
The approval assumes significance as it will not only help the government ramp up vaccination but also play a crucial role in immunising children between 12-18 years age once supplies improve going forward.
The DNA-based vaccine is the sixth jab against SARS-CoV2 to get emergency use authorisation in India. So far, Covishield, Covaxin, Sputnik V are available in India, whereas vaccines developed by Moderna and J&J have also been approved with emergency authorisation.
Till 9pm on Friday, a total of over 57.48 crore doses of anti-Covid jabs have been administered across the country.
The three-dose vaccine, developed in partnership with the department of biotechnology, has been approved with a dosage cycle where the second and third shot of the jab will be administered in an interval of 28 days and 56 days from the first dose, respectively.
Interim results of ZyCoV-D from Phase-3 clinical trials, in over 28,000 volunteers, showed primary efficacy of 66.6% for symptomatic RT-PCR positive cases. This has been the largest vaccine trial so far in India for Covid-19.
The Ahmedabad company has also conducted phase 2 study for two doses of the vaccine but is yet to apply for the phase 3.


Source link